Early modulation of inflammation by mesenchymal stem cells after acute kidney injury.

This study analyzed whether immune modulation continues after 24 hours of reperfusion in stem cell therapy of acute kidney injury. The data demonstrated that the immunomodulatory effects of mesenchymal stem cells occur at very early time point, changing the inflammation profile.